Duško Lainšček

1.3k total citations
43 papers, 879 citations indexed

About

Duško Lainšček is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Duško Lainšček has authored 43 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Immunology and 9 papers in Oncology. Recurrent topics in Duško Lainšček's work include CAR-T cell therapy research (9 papers), Immune Response and Inflammation (7 papers) and Immune Cell Function and Interaction (6 papers). Duško Lainšček is often cited by papers focused on CAR-T cell therapy research (9 papers), Immune Response and Inflammation (7 papers) and Immune Cell Function and Interaction (6 papers). Duško Lainšček collaborates with scholars based in Slovenia, United States and United Kingdom. Duško Lainšček's co-authors include Roman Jerala, Iva Hafner‐Bratkovič, Mojca Benčina, Tina Lebar, Jana Aupič, Estera Merljak, Jelka Pohar, Rok Romih, Simon Horvat and Mateja Manček‐Keber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Duško Lainšček

40 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duško Lainšček Slovenia 17 631 214 74 68 63 43 879
Makoto Nakakido Japan 19 876 1.4× 126 0.6× 62 0.8× 118 1.7× 39 0.6× 81 1.2k
Jaclyn Milton United States 8 473 0.7× 263 1.2× 119 1.6× 46 0.7× 77 1.2× 10 867
Samar Abdulkhalek Canada 14 412 0.7× 232 1.1× 38 0.5× 109 1.6× 86 1.4× 17 691
Shane Miersch Canada 14 429 0.7× 72 0.3× 52 0.7× 50 0.7× 52 0.8× 34 714
Marcio C. Bajgelman Brazil 18 407 0.6× 121 0.6× 40 0.5× 125 1.8× 123 2.0× 45 735
Krishnakumar N. Menon India 15 343 0.5× 150 0.7× 42 0.6× 66 1.0× 28 0.4× 40 728
Xue Wen China 17 177 0.3× 174 0.8× 59 0.8× 56 0.8× 41 0.7× 56 653
Jiyeon Jang South Korea 13 286 0.5× 170 0.8× 54 0.7× 58 0.9× 47 0.7× 16 859
Christopher Campbell United States 12 710 1.1× 76 0.4× 44 0.6× 53 0.8× 135 2.1× 50 1.0k

Countries citing papers authored by Duško Lainšček

Since Specialization
Citations

This map shows the geographic impact of Duško Lainšček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duško Lainšček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duško Lainšček more than expected).

Fields of papers citing papers by Duško Lainšček

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duško Lainšček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duško Lainšček. The network helps show where Duško Lainšček may publish in the future.

Co-authorship network of co-authors of Duško Lainšček

This figure shows the co-authorship network connecting the top 25 collaborators of Duško Lainšček. A scholar is included among the top collaborators of Duško Lainšček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duško Lainšček. Duško Lainšček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lainšček, Duško, et al.. (2025). Enhancing CAR T-Cell Function with Domains of Innate Immunity Sensors. International Journal of Molecular Sciences. 26(3). 1339–1339. 1 indexed citations
2.
Lebar, Tina, et al.. (2025). Ligand-induced assembly of antibody variable fragments for the chemical regulation of biological processes. Cell chemical biology. 32(3). 474–485.e5.
3.
Lainšček, Duško, et al.. (2025). CTNNB1 syndrome mouse models. Mammalian Genome. 36(2). 390–402.
4.
Gosar, David, Špela Miroševič, Stephan Sanders, et al.. (2025). Genotypic, functional, and phenotypic characterization in CTNNB1 neurodevelopmental syndrome. Human Genetics and Genomics Advances. 6(4). 100483–100483. 1 indexed citations
5.
Plaper, Tjaša, Estera Merljak, Ajasja Ljubetič, et al.. (2024). Designed allosteric protein logic. Cell Discovery. 10(1). 8–8. 13 indexed citations
6.
Lainšček, Duško, Urška Kuhar, Sandra Janežič, et al.. (2024). TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower inflammatory consequences. Antiviral Research. 222. 105806–105806. 4 indexed citations
7.
Petan, Toni, et al.. (2024). Abstract 2288 Lipid Droplets as Orchestrators of Lipid Mediator Signaling and Ferroptotic Cell Death. Journal of Biological Chemistry. 300(3). 106402–106402. 1 indexed citations
8.
Lainšček, Duško, et al.. (2024). Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors. Nature Communications. 15(1). 10801–10801. 13 indexed citations
9.
Lainšček, Duško, et al.. (2024). Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors. SHILAP Revista de lepidopterología. 32(2). 200815–200815. 5 indexed citations
10.
Kuhar, Urška, et al.. (2023). Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research. Animals. 13(16). 2616–2616. 1 indexed citations
11.
Miroševič, Špela, et al.. (2022). Correlation between Phenotype and Genotype in CTNNB1 Syndrome: A Systematic Review of the Literature. International Journal of Molecular Sciences. 23(20). 12564–12564. 21 indexed citations
12.
Avbelj, Monika, Iva Hafner‐Bratkovič, Duško Lainšček, et al.. (2022). Cleavage-Mediated Regulation of Myd88 Signaling by Inflammasome-Activated Caspase-1. Frontiers in Immunology. 12. 790258–790258. 14 indexed citations
13.
Manček‐Keber, Mateja, Iva Hafner‐Bratkovič, Duško Lainšček, et al.. (2021). Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. The FASEB Journal. 35(6). e21651–e21651. 41 indexed citations
14.
Lainšček, Duško, Bernd Gesslbauer, Eva Jarc Jovičić, et al.. (2020). Synergy between 15-lipoxygenase and secreted PLA 2 promotes inflammation by formation of TLR4 agonists from extracellular vesicles. Proceedings of the National Academy of Sciences. 117(41). 25679–25689. 17 indexed citations
15.
Lebar, Tina, Duško Lainšček, Estera Merljak, Jana Aupič, & Roman Jerala. (2020). A tunable orthogonal coiled-coil interaction toolbox for engineering mammalian cells. Nature Chemical Biology. 16(5). 513–519. 88 indexed citations
16.
Hafner‐Bratkovič, Iva, Duško Lainšček, Ana Tapia‐Abellán, et al.. (2018). NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway. Nature Communications. 9(1). 5182–5182. 107 indexed citations
17.
Pohar, Jelka, et al.. (2017). Short single-stranded DNA degradation products augment the activation of Toll-like receptor 9. Nature Communications. 8(1). 15363–15363. 39 indexed citations
18.
Smole, Anže, et al.. (2017). A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation. Molecular Therapy. 25(1). 102–119. 42 indexed citations
19.
Ljubetič, Ajasja, Fabio Lapenta, Helena Gradišar, et al.. (2017). Design of coiled-coil protein-origami cages that self-assemble in vitro and in vivo. Nature Biotechnology. 35(11). 1094–1101. 136 indexed citations
20.
Oblak, Alja, Duško Lainšček, José L. Jiménez Blanco, et al.. (2014). Trehalose- and Glucose-Derived Glycoamphiphiles: Small-Molecule and Nanoparticle Toll-Like Receptor 4 (TLR4) Modulators. Journal of Medicinal Chemistry. 57(21). 9105–9123. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026